Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: r...

por Longo-Muñoz, F., Argiles, G., Tabernero, J., Cervantes, A., Gravalos, C., Pericay, C., Gil-Calle, S., Mizuguchi, H., Carrato-Mena, A., Limón, M. L., Garcia-Carbonero , R.
Publicado 2016

1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)

por Serrano Domingo, J.J., Corral de la Fuente, E., Martin Huertas, R., Vida Navas, E.M., Soto Castillo, J.J., Sanz Gomez, L., Torres Jimenez, J., Esteban Villarrubia, J., Orejana Martin, I., Alvarez Ballesteros, P., Pozas Perez, J., San Roman Gil, M.V., Garrido Lopez, P., Carrato Mena, A.
Publicado 2020

112P Immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in cancer patients receiving immunotherapy agents

por Muñoz, F. Longo, Salgado, A. Cortés, Domingo, J.J. Serrano, Casado, J.L., Vallejo, A., Serrano, C. Saavedra, Pérez, J. Chamorro, Rodríguez, D.I. Rosero, Velasco, H., Martin, A., Soria, A., Garcia, M.E. Olmedo, Rueda, A. Gomez, Lage, Y., Gordoa, T. Alonso, Cerrillo, J. Molina, Borau, P. Gajate, Martínez del Frade, Í., Lopez, P. Garrido, Carrato-Mena, A.
Publicado 2021